GGrantIndex
Sort

51,593 grants matching hepatitis

Development of a 3D multi-modal perfusion-thermal electrode system

$627,588
Xiaoming Yang · University Of Washington · R01 · FY2020 · EB

Targeting KLF2 in macrophages to improve immune checkpoint therapy for hepatocellular cancer

$627,562
Guangfu Li · University Of Connecticut Sch Of Med/Dnt · R01 · FY2025 · CA

A Novel computational approach to optimize Fontan and improve surgical predictability

$627,547
Vijay Govindarajan · Boston Children'S Hospital · R01 · FY2022 · HL

Fully Automated High-Throughput Quantitative MRI of the Liver

$627,507
Scott B. Reeder · University Of Wisconsin-Madison · R01 · FY2023 · EB

Genetic Modifiers of CF Liver Disease

$627,428
Michael R Knowles · Univ Of North Carolina Chapel Hill · R01 · FY2007 · DK

Development of a novel drug candidate that inhibits hepatitis B virus covalently

$627,419
Haitao Guo · Drexel University · R01 · FY2012 · AI

Molecular MR Imaging of Hepatic Fibrogenesis

$627,398
Peter D Caravan · Massachusetts General Hospital · R01 · FY2021 · DK

Understanding the Multilevel Drivers of Liver Cancer Disparities

$627,382
Salma Shariff-Marco · University Of California, San Francisco · R01 · FY2023 · CA

Case Management Alternatives for African American Women at High Risk for HIV

$627,359
James A Inciardi · University Of Delaware · R01 · FY2007 · DA

Natural history, risk prediction and cost of cirrhosis in insured Americans.

$627,330
Daniela P Ladner · Northwestern University At Chicago · R01 · FY2025 · DK

SYRINGE EXCHANGE PEER MOBILIZATION INTERVENTION

$627,304
University Of California San Francisco · R01 · FY2002 · DA

In pursuit of a one-stop shop: a hybrid type 1 effectiveness-implementation trial of comprehensive tele-health concierge for people who inject drugs

$627,298
Hansel Emory Tookes · University Of Miami School Of Medicine · R01 · FY2025 · DA

Social networks and HIV risk among rural drug users

$627,278
Jennifer R Havens · University Of Kentucky · R01 · FY2010 · DA

LIVOPT -- LIVer cirrhosis - Optimizing Prediction of Patient OuTcomes

$627,274
Daniela P Ladner · Northwestern University At Chicago · R01 · FY2021 · AG

Quantitative ECT for Complex Imaging Tasks

$627,190
Stephen C Moore · Brigham And Women'S Hospital · R01 · FY2011 · EB

HCV IRES Control of Human Translational Initiation

$627,169
Jennifer A Doudna · University Of California Berkeley · R56 · FY2011 · AI

The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials Network

$627,148
Jose Szapocznik · University Of Miami School Of Medicine · UG1 · FY2017 · DA

Fully Automated High-Throughput Quantitative MRI of the Liver

$627,116
Scott B. Reeder · University Of Wisconsin-Madison · R01 · FY2022 · EB

Cross-talk between the circadian clock and the cAMP signaling pathway

$627,054
Marc R Montminy · Salk Institute For Biological Studies · R01 · FY2012 · DK

Cross-talk between the circadian clock and the cAMP signaling pathway

$627,054
Marc R Montminy · Salk Institute For Biological Studies · R01 · FY2015 · DK

Cross-talk between the circadian clock and the cAMP signaling pathway

$627,054
Marc R Montminy · Salk Institute For Biological Studies · R01 · FY2014 · DK

Gigapixel digital PCR in Giant Unilamellar Vesicles

$627,044
Adam R. Abate · University Of California, San Francisco · R01 · FY2020 · EB

CSDE1 as a Post Transcriptional Regulator of the LDLR

$626,993
John S Chorba · University Of California, San Francisco · R01 · FY2022 · HL

Licensing LncRNAs in Atherosclerosis

$626,961
Tamer Sallam · University Of California Los Angeles · R01 · FY2021 · HL

Licensing LncRNAs in Atherosclerosis

$626,961
Tamer Sallam · University Of California Los Angeles · R01 · FY2022 · HL